البحث عن طبيب

Alina M. Allen, M.D.

  1. Gastroenterologist
  2. Internist
  3. Transplant Hepatologist
طلب موعد

المنشورات

  1. Allen AM, Arab JP, Wong VW. MASLD: a disease in flux. Nat Rev Gastroenterol Hepatol. 2024 Nov; 21 (11):747-750 Epub 2024 Oct 02
    View PubMed
  2. Allen AM, Younossi ZM, Diehl AM, Charlton MR, Lazarus JV. Envisioning how to advance the MASH field. Nat Rev Gastroenterol Hepatol. 2024 Oct; 21 (10):726-738 Epub 2024 June 04
    View PubMed
  3. Udompap P, Liu K, Attia IZ, Canning RE, Benson JT, Therneau TM, Noseworthy PA, Friedman PA, Rattan P, Ahn JC, Simonetto DA, Shah VH, Kamath PS, Allen AM. Performance of AI-Enabled Electrocardiogram in the Prediction of Metabolic Dysfunction-Associated Steatotic Liver Disease. Clin Gastroenterol Hepatol. 2024 Aug 27 [Epub ahead of print]
    View PubMed
  4. Ivancovsky Wajcman D, Byrne CJ, Dillon JF, Brennan PN, Villota-Rivas M, Younossi ZM, Allen AM, Crespo J, Gerber LH, Lazarus JV. A narrative review of lifestyle management guidelines for metabolic dysfunction-associated steatotic liver disease. Hepatology. 2024 Aug 15 [Epub ahead of print]
    View PubMed
  5. Tsochatzis EA, Valenti L, Thiele M, Peloquin S, Lazure P, Masson MH, Allen AM, Lazarus JV, Noureddin M, Rinella M, Tacke F, Murray S. Use of non-invasive diagnostic tools for metabolic dysfunction-associated steatohepatitis: A qualitative exploration of challenges and barriers. Liver Int. 2024 Aug; 44 (8):1990-2001 Epub 2024 Apr 18
    View PubMed
  6. Younossi ZM, AlQahtani SA, Funuyet-Salas J, Romero-Gomez M, Yilmaz Y, Keklikkiran C, Alswat K, Yu ML, Liu CJ, Fan JG, Zheng MH, Burra P, Francque SM, Castera L, Schattenberg JM, Newsome PN, Allen AM, El-Kassas M, Treeprasertsuk S, Hameed S, Wai-Sun Wong V, Zelber-Sagi S, Takahashi H, Kawaguchi T, Castellanos Fernandez MI, Duseja A, Arrese M, Rinella M, Singal AK, Gordon SC, Fuchs M, Eskridge W, Alkhouri N, Cusi K, Loomba R, Ranagan J, Kautz A, Ong JP, Kugelmas M, Eguchi Y, Diago M, Gerber L, Lam B, Fornaresio L, Nader F, Spearman CW, Roberts SK, Chan WK, Silva M, Racila A, Golabi P, Ananchuensook P, Henry L, Stepanova M, Carrieri P, Lazarus JV, Global NASH Council. The impact of stigma on quality of life and liver disease burden among patients with nonalcoholic fatty liver disease. JHEP Rep. 2024 Jul; 6 (7):101066 Epub 2024 Mar 12
    View PubMed
  7. Noureddin N, Huang DQ, Bettencourt R, Siddiqi H, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Gidener T, Allen AM, Ajmera V, Loomba R. Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction-associated steatotic liver disease. Aliment Pharmacol Ther. 2024 Jun; 59 (12):1521-1526 Epub 2024 Apr 03
    View PubMed
  8. Rule AD, Grossardt BR, Weston AD, Garner HW, Kline TL, Chamberlain AM, Allen AM, Erickson BJ, Rocca WA, St Sauver JL. Older Tissue Age Derived From Abdominal Computed Tomography Biomarkers of Muscle, Fat, and Bone Is Associated With Chronic Conditions and Higher Mortality. Mayo Clin Proc. 2024 Jun; 99 (6):878-890 Epub 2024 Feb 02
    View PubMed
  9. Heimbach JK, Allen AM. Improved Prioritization of the Liver Transplant Waitlist: Weighing the Risks. Transplantation. 2024 May 1; 108 (5):1062-1063 Epub 2023 Nov 13
    View PubMed
  10. AbiMansour J, Chin JY, Kaur J, Vargas EJ, Abu Dayyeh BK, Law R, Garimella V, Levy MJ, Storm AC, Dierkhising R, Allen A, Venkatesh S, Chandrasekhara V. Endoscopic Ultrasound-based Shear Wave Elastography for Detection of Advanced Liver Disease. J Clin Gastroenterol. 2024 Apr 23 [Epub ahead of print]
    View PubMed
  11. Allen AM, Charlton M, Cusi K, Harrison SA, Kowdley KV, Noureddin M, Shubrook JH. Guideline-based management of metabolic dysfunction-associated steatotic liver disease in the primary care setting. Postgrad Med. 2024 Apr; 136 (3):229-245 Epub 2024 May 13
    View PubMed
  12. Li J, Allen AM, Yin M. Reply: Comparing quantitative MRI technologies in steatotic liver disease. Hepatology. 2024 Apr 1; 79 (4):E121-E122 Epub 2023 Nov 08
    View PubMed
  13. Weston AD, Grossardt BR, Garner HW, Kline TL, Chamberlain AM, Allen AM, Erickson BJ, Rocca WA, Rule AD, St Sauver JL. Abdominal Body Composition Reference Ranges and Association With Chronic Conditions in an Age- and Sex-Stratified Representative Sample of a Geographically Defined American Population. J Gerontol A Biol Sci Med Sci. 2024 Apr 1; 79 (4)
    View PubMed
  14. Brennan PN, Zelber-Sagi S, Allen AM, Dillon JF, Lazarus JV. Beyond a liver-gut focus: the evolution of gastroenterology and hepatology in challenging the obesity and steatotic liver disease paradigm. Gut 2024 Mar 7; 73 (4):560-563 Epub 2024 Mar 07
    View PubMed
  15. Younossi ZM, Alqahtani SA, Alswat K, Yilmaz Y, Keklikkiran C, Funuyet-Salas J, Romero-Gomez M, Fan JG, Zheng MH, El-Kassas M, Castera L, Liu CJ, Wai-Sun Wong V, Zelber-Sagi S, Allen AM, Lam B, Treeprasertsuk S, Hameed S, Takahashi H, Kawaguchi T, Schattenberg JM, Duseja A, Newsome PN, Francque S, Spearman CW, Castellanos Fernandez MI, Burra P, Roberts SK, Chan WK, Arrese M, Silva M, Rinella M, Singal AK, Gordon S, Fuchs M, Alkhouri N, Cusi K, Loomba R, Ranagan J, Eskridge W, Kautz A, Ong JP, Kugelmas M, Eguchi Y, Diago M, Yu ML, Gerber L, Fornaresio L, Nader F, Henry L, Racila A, Golabi P, Stepanova M, Carrieri P, Lazarus JV, Global NASH Council. Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease. J Hepatol. 2024 Mar; 80 (3):419-430 Epub 2023 Nov 18
    View PubMed
  16. Allen AM, Pose E, Reddy KR, Russo MW, Kamath PS. Nonalcoholic Fatty Liver Disease Gets Renamed as Metabolic Dysfunction-Associated Steatotic Liver Disease: Progress But With Challenges. Gastroenterology. 2024 Feb; 166 (2):229-234 Epub 2023 Nov 08
    View PubMed
  17. Lazarus JV, Mark HE, Allen AM, Arab JP, Carrieri P, Noureddin M, Alazawi W, Alkhouri N, Alqahtani SA, Anstee QM, Arrese M, Bataller R, Berg T, Brennan PN, Burra P, Castro-Narro GE, Cortez-Pinto H, Cusi K, Dedes N, Duseja A, Francque SM, Gastaldelli A, Hagstrom H, Huang TTK, Ivancovsky Wajcman D, Kautz A, Kopka CJ, Krag A, Newsome PN, Rinella ME, Romero D, Sarin SK, Silva M, Spearman CW, Terrault NA, Tsochatzis EA, Valenti L, Villota-Rivas M, Zelber-Sagi S, Schattenberg JM, Wong VW, Younossi ZM, Healthy Livers, Healthy Lives Collaborators. A global action agenda for turning the tide on fatty liver disease. Hepatology. 2024 Feb 1; 79 (2):502-523 Epub 2023 Aug 04
    View PubMed
  18. Hagstrom H, Adams LA, Allen AM, Byrne CD, Chang Y, Duseja A, Gronbaek H, Ismail MH, Jepsen P, Kanwal F, Kramer J, Loomba R, Mark HE, Newsome PN, Rinella ME, Rowe IA, Ryu S, Sanyal A, Schattenberg JM, Serper M, Sheron N, Simon TG, Spearman CW, Tapper EB, Villota-Rivas M, Wild SH, Wong VW, Yilmaz Y, Zelber-Sagi S, Aberg F, Lazarus JV. The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement. Hepatol Commun. 2024 Feb 1; 8 (2) Epub 2024 Feb 03
    View PubMed
  19. Abeysekera KWM, Valenti L, Younossi Z, Dillon JF, Allen AM, Nourredin M, Rinella ME, Tacke F, Francque S, Gines P, Thiele M, Newsome PN, Guha IN, Eslam M, Schattenberg JM, Alqahtani SA, Arrese M, Berzigotti A, Holleboom AG, Caussy C, Cusi K, Roden M, Hagstrom H, Wong VW, Mallet V, Castera L, Lazarus JV, Tsochatzis EA. Implementation of a liver health check in people with type 2 diabetes. Lancet Gastroenterol Hepatol. 2024 Jan; 9 (1):83-91
    View PubMed
  20. Lim YS, Kwong AJ, Allen AM. Introducing W. Ray Kim, MD, our 2024 AASLD president. Hepatology. 2024 Jan 1; 79 (1):21-24 Epub 2023 Oct 30
    View PubMed
  21. Kim BK, Bergstrom J, Loomba R, Tamaki N, Izumi N, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Truong E, Yang JD, Noureddin M, Allen AM, Loomba R, Ajmera V. Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study. Hepatology. 2023 Dec 1; 78 (6):1858-1866 Epub 2023 May 22
    View PubMed
  22. Allen A, Berg T, Charlton M, Shapiro D, Watt K, Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, Romero D, Abdelmalek MF, Anstee QM, Arab JP, Arrese M, Bataller R, Beuers U, Boursier J, Bugianesi E, Byrne CD, Castro Narro GE, Chowdhury A, Cortez-Pinto H, Cryer DR, Cusi K, El-Kassas M, Klein S, Eskridge W, Fan J, Gawrieh S, Guy CD, Harrison SA, Kim SU, Koot BG, Korenjak M, Kowdley KV, Lacaille F, Loomba R, Mitchell-Thain R, Morgan TR, Powell EE, Roden M, Romero-Gomez M, Silva M, Singh SP, Sookoian SC, Spearman CW, Tiniakos D, Valenti L, Vos MB, Wong VW, Xanthakos S, Yilmaz Y, Younossi Z, Hobbs A, Villota-Rivas M, Newsome PN, NAFLD Nomenclature consensus group. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023 Dec 1; 78 (6):1966-1986 Epub 2023 June 24
    View PubMed
  23. Ivancovsky-Wajcman D, Brennan PN, Kopka CJ, Zelber-Sagi S, Younossi ZM, Allen AM, Florez KR, Lazarus JV. Integrating social nutrition principles into the treatment of steatotic liver disease. Commun Med (Lond). 2023 Nov 10; 3 (1):165
    View PubMed
  24. Lazarus JV, Kopka CJ, Younossi ZM, Allen AM. It is time to expand the fatty liver disease community of practice. Hepatology. 2023 Nov 1; 78 (5):1325-1328 Epub 2023 June 23
    View PubMed
  25. Allen AM, Younossi ZM, Tsochatzis EA, Alazawi W, Zelber-Sagi S, Arab JP, Cusi K, Lazarus JV. Measuring NAFLD models of care. Nat Rev Gastroenterol Hepatol. 2023 Oct; 20 (10):626-627
    View PubMed
  26. Li J, Lu X, Zhu Z, Kalutkiewicz KJ, Mounajjed T, Therneau TM, Venkatesh SK, Sui Y, Glaser KJ, Hoodeshenas S, Manduca A, Shah VH, Ehman RL, Allen AM, Yin M. Head-to-head comparison of magnetic resonance elastography-based liver stiffness, fat fraction, and T1 relaxation time in identifying at-risk NASH. Hepatology. 2023 Oct 1; 78 (4):1200-1208 Epub 2023 May 01
    View PubMed
  27. Eskridge W, Cryer DR, Schattenberg JM, Gastaldelli A, Malhi H, Allen AM, Noureddin M, Sanyal AJ. Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective. J Clin Med. 2023 Sep 26; 12 (19) Epub 2023 Sept 26
    View PubMed
  28. Serra-Burriel M, Juanola A, Serra-Burriel F, Thiele M, Graupera I, Pose E, Pera G, Grgurevic I, Caballeria L, Piano S, van Kleef L, Reichert M, Roulot D, Pericas JM, Schattenberg JM, Tsochatztis EA, Guha IN, Garcia-Retortillo M, Hernandez R, Hoyo J, Fuentes M, Exposito C, Martinez A, Such P, Madir A, Detlefsen S, Tonon M, Martini A, Ma AT, Pich J, Bonfill E, Juan M, Soria A, Carol M, Gratacos-Gines J, Morillas RM, Toran P, Navarrete JM, Torrejon A, Fournier C, Llorca A, Arslanow A, de Koning HJ, Cucchietti F, Manns M, Newsome PN, Hernaez R, Allen A, Angeli P, de Knegt RJ, Karlsen TH, Galle P, Wong VW, Fabrellas N, Castera L, Krag A, Lammert F, Kamath PS, Gines P, LiverScreen Consortium Investigators. Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study. Lancet. 2023 Sep 16; 402 (10406):988-996 Epub 2023 Aug 09
    View PubMed
  29. Huang DQ, Noureddin N, Ajmera V, Amangurbanova M, Bettencourt R, Truong E, Gidener T, Siddiqi H, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Yoneda M, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Allen AM, Noureddin M, Loomba R. Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis. Lancet Gastroenterol Hepatol. 2023 Sep; 8 (9):829-836 Epub 2023 July 04
    View PubMed
  30. Patel K, Shapiro D, Lazarus JV, Mark HE, Allen AM, Arab JP, Carrieri P, Noureddin M, Alazawi W, Alkhouri N, Alqahtani SA, Arrese M, Bataller R, Berg T, Brennan PN, Burra P, Castro-Narro GE, Cortez-Pinto H, Cusi K, Dedes N, Duseja A, Francque SM, Hagstrom H, Huang TT, Wajcman DI, Kautz A, Kopka CJ, Krag A, Miller V, Newsome PN, Rinella ME, Romero D, Sarin SK, Silva M, Spearman CW, Tsochatzis EA, Valenti L, Villota-Rivas M, Zelber-Sagi S, Schattenberg JM, Wong VW, Younossi ZM, Healthy Livers, Healthy Lives Collaborators. A global research priority agenda to advance public health responses to fatty liver disease. J Hepatol. 2023 Sep; 79 (3):618-634 Epub 2023 June 20
    View PubMed
  31. Stine JG, Long MT, Corey KE, Sallis RE, Allen AM, Armstrong MJ, Conroy DE, Cuthbertson DJ, Duarte-Rojo A, Hallsworth K, Hickman IJ, Kappus MR, Keating SE, Pugh CJA, Rotman Y, Simon TL, Vilar-Gomez E, Wong VW, Schmitz KH. Physical Activity and Nonalcoholic Fatty Liver Disease: A Roundtable Statement from the American College of Sports Medicine. Med Sci Sports Exerc. 2023 Sep 1; 55 (9):1717-1726
    View PubMed
  32. Allen AM, Lazarus JV, Younossi ZM. Healthcare and socioeconomic costs of NAFLD: A global framework to navigate the uncertainties. J Hepatol. 2023 Jul; 79 (1):209-217 Epub 2023 Feb 04
    View PubMed
  33. Rowe IA, Allen AM. Hepatic steatosis provides the terroir that promotes the development of cardiovascular risk factors and disease. Hepatology 2023 Jun 1; 77 (6):1843-1845 Epub 2023 Feb 06
    View PubMed
  34. Stine JG, Long MT, Corey KE, Sallis RE, Allen AM, Armstrong MJ, Conroy DE, Cuthbertson DJ, Duarte-Rojo A, Hallsworth K, Hickman IJ, Kappus MR, Keating SE, Pugh CJA, Rotman Y, Simon TG, Vilar-Gomez E, Wong VW, Schmitz KH. American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver disease. Hepatol Commun. 2023 Apr 1; 7 (4) Epub 2023 Mar 30
    View PubMed
  35. Harrison SA, Allen AM, Dubourg J, Noureddin M, Alkhouri N. Challenges and opportunities in NASH drug development. Nat Med. 2023 Mar; 29 (3):562-573 Epub 2023 Mar 09
    View PubMed
  36. Udompap P, Therneau TM, Canning RE, Benson JT, Allen AM. Performance of American Gastroenterological Association Clinical Care Pathway for the risk stratification of patients with nonalcoholic fatty liver disease in the US population. Hepatology. 2023 Mar 1; 77 (3):931-941 Epub 2023 Feb 17
    View PubMed
  37. Schattenberg JM, Allen AM, Jarvis H, Zelber-Sagi S, Cusi K, Dillon JF, Caussy C, Francque SM, Younossi Z, Alkhouri N, Lazarus JV. A multistakeholder approach to innovations in NAFLD care. Commun Med (Lond). 2023 Jan 3; 3 (1):1 Epub 2023 Jan 03
    View PubMed
  38. Gidener T, Dierkhising RA, Mara KC, Therneau TM, Venkatesh SK, Ehman RL, Yin M, Allen AM. Change in serial liver stiffness measurement by magnetic resonance elastography and outcomes in NAFLD. Hepatology. 2023 Jan 1; 77 (1):268-274 Epub 2022 June 20
    View PubMed
  39. Therneau TM, Mounajjed T, Glaser KJ, Venkatesh SK, Li J, Allen AM, Shah VH, Manduca A, Ehman RL, Yin M, NAFLD MR Imaging Research Group. Longitudinal Changes in MR Elastography-based Biomarkers in Obese Patients Treated with Bariatric Surgery. Clin Gastroenterol Hepatol. 2023 Jan; 21 (1):220-222.e3 Epub 2021 Oct 30
    View PubMed
  40. Lazarus JV, Castera L, Mark HE, Allen AM, Adams LA, Anstee QM, Arrese M, Alqahtani SA, Bugianesi E, Colombo M, Cusi K, Hagstrom H, Loomba R, Romero-Gomez M, Schattenberg JM, Thiele M, Valenti L, Wong VW, Yilmaz Y, Younossi ZM, Francque SM, Tsochatzis EA. Real-world evidence on non-invasive tests and associated cut-offs used to assess fibrosis in routine clinical practice. JHEP Rep. 2023 Jan; 5 (1):100596 Epub 2022 Sept 22
    View PubMed
  41. Allen AM, Therneau TM, Ahmed OT, Gidener T, Mara KC, Larson JJ, Canning RE, Benson JT, Kamath PS. Clinical course of non-alcoholic fatty liver disease and the implications for clinical trial design. J Hepatol. 2022 Nov; 77 (5):1237-1245 Epub 2022 July 16
    View PubMed
  42. Ajmera V, Kim BK, Yang K, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Quach NE, Tu X, Zhang X, Noureddin M, Allen AM, Loomba R. Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants. Gastroenterology. 2022 Oct; 163 (4):1079-1089.e5 Epub 2022 July 02
    View PubMed
  43. Wang XJ, Borah B, Rojas R, Kamath MJ, Moriarty J, Allen AM, Kamath PS. Patients Hospitalized for Complications of Cirrhosis may Have Benefited From Medicaid Expansion Under the Affordable Care Act. Mayo Clin Proc Innov Qual Outcomes. 2022 Aug; 6 (4):291-301 Epub 2022 June 11
    View PubMed
  44. Nasser-Ghodsi N, Mara K, Allen AM, Watt KD. Increasing nonalcoholic steatohepatitis overlap in liver transplant recipients: Additive risk for de novo malignancy. Clin Transplant. 2022 Aug; 36 (8):e14714 Epub 2022 June 02
    View PubMed
  45. Ahmed OT, Gidener T, Mara KC, Larson JJ, Therneau TM, Allen AM. Natural History of Nonalcoholic Fatty Liver Disease With Normal Body Mass Index: A Population-Based Study. Clin Gastroenterol Hepatol. 2022 Jun; 20 (6):1374-1381.e6 Epub 2021 July 13
    View PubMed
  46. Choi C, Lennon RJ, Choi DH, Serafim LP, Allen AM, Kamath PS, Shah VH, de Moraes AG, Simonetto DA. Relationship Between Body Mass Index and Survival Among Critically Ill Patients With Cirrhosis. J Intensive Care Med. 2022 Jun; 37(6):817-824. Epub 2021 Jul 05.
    View PubMed
  47. Ahn JC, Attia ZI, Rattan P, Mullan AF, Buryska S, Allen AM, Kamath PS, Friedman PA, Shah VH, Noseworthy PA, Simonetto DA. Development of the AI-Cirrhosis-ECG Score: An Electrocardiogram-Based Deep Learning Model in Cirrhosis. Am J Gastroenterol. 2022 Mar 1; 117 (3):424-432
    View PubMed
  48. Gidener T, Yin M, Dierkhising RA, Allen AM, Ehman RL, Venkatesh SK. Magnetic resonance elastography for prediction of long-term progression and outcome in chronic liver disease: A retrospective study. Hepatology. 2022 Feb; 75 (2):379-390 Epub 2021 Dec 15
    View PubMed
  49. Chen J, Allen AM, Therneau TM, Chen J, Li J, Hoodeshenas S, Chen J, Lu X, Zhu Z, Venkatesh SK, Song B, Ehman RL, Yin M. Liver stiffness measurement by magnetic resonance elastography is not affected by hepatic steatosis. Eur Radiol. 2022 Feb; 32 (2):950-958 Epub 2021 Aug 25
    View PubMed
  50. Gines P, Castera L, Lammert F, Graupera I, Serra-Burriel M, Allen AM, Wong VW, Hartmann P, Thiele M, Caballeria L, de Knegt RJ, Grgurevic I, Augustin S, Tsochatzis EA, Schattenberg JM, Guha IN, Martini A, Morillas RM, Garcia-Retortillo M, de Koning HJ, Fabrellas N, Pich J, Ma AT, Diaz MA, Roulot D, Newsome PN, Manns M, Kamath PS, Krag A, LiverScreen Consortium Investigators. Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases. Hepatology. 2022 Jan; 75 (1):219-228 Epub 2021 Dec 10
    View PubMed
  51. O'Shea RS, Davitkov P, Ko CW, Rajasekhar A, Su GL, Sultan S, Allen AM, Falck-Ytter Y. AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis. Gastroenterology. 2021 Nov; 161 (5):1615-1627.e1 Epub 2021 Sept 25
    View PubMed
  52. Intagliata NM, Davitkov P, Allen AM, Falck-Ytter YT, Stine JG. AGA Technical Review on Coagulation in Cirrhosis. Gastroenterology. 2021 Nov; 161 (5):1630-1656 Epub 2021 Sept 25
    View PubMed
  53. Buryska S, Ahn JC, Allen AM, Simha V, Simonetto DA. Familial Hypobetalipoproteinemia: An Underrecognized Cause of Lean NASH. Hepatology. 2021 Nov; 74(5):2897-2898. Epub 2021 Jul 08.
    View PubMed
  54. Gidener T, Ahmed OT, Larson JJ, Mara KC, Therneau TM, Venkatesh SK, Ehman RL, Yin M, Allen AM. Liver Stiffness by Magnetic Resonance Elastography Predicts Future Cirrhosis, Decompensation, and Death in NAFLD. Clin Gastroenterol Hepatol. 2021 Sep; 19 (9):1915-1924.e6 Epub 2020 Sept 30
    View PubMed
  55. Nakao Y, Amrollahi P, Parthasarathy G, Mauer AS, Sehrawat TS, Vanderboom P, Nair KS, Nakao K, Allen AM, Hu TY, Malhi H. Circulating extracellular vesicles are a biomarker for NAFLD resolution and response to weight loss surgery. Nanomedicine. 2021 Aug; 36:102430 Epub 2021 June 24
    View PubMed
  56. Hagstrom H, Adams LA, Allen AM, Byrne CD, Chang Y, Gronbaek H, Ismail M, Jepsen P, Kanwal F, Kramer J, Lazarus JV, Long MT, Loomba R, Newsome PN, Rowe IA, Ryu S, Schattenberg JM, Serper M, Sheron N, Simon TG, Tapper EB, Wild S, Wong VW, Yilmaz Y, Zelber-Sagi S, Aberg F. Administrative Coding in Electronic Health Care Record-Based Research of NAFLD: An Expert Panel Consensus Statement. Hepatology. 2021 Jul; 74 (1):474-482 Epub 2021 June 22
    View PubMed
  57. Dzyubak B, Li J, Chen J, Mara KC, Therneau TM, Venkatesh SK, Ehman RL, Allen AM, Yin M. Automated Analysis of Multiparametric Magnetic Resonance Imaging/Magnetic Resonance Elastography Exams for Prediction of Nonalcoholic Steatohepatitis. J Magn Reson Imaging. 2021 Jul; 54 (1):122-131 Epub 2021 Feb 15
    View PubMed
  58. Idilman IS, Low HM, Gidener T, Philbrick K, Mounajjed T, Li J, Allen AM, Yin M, Venkatesh SK. Association between Visceral Adipose Tissue and Non-Alcoholic Steatohepatitis Histology in Patients with Known or Suspected Non-Alcoholic Fatty Liver Disease. J Clin Med. 2021 Jun 10; 10 (12) Epub 2021 June 10
    View PubMed
  59. Nakao Y, Fukushima M, Mauer AS, Liao CY, Ferris A, Dasgupta D, Heppelmann CJ, Vanderboom PM, Saraswat M, Pandey A, Nair KS, Allen AM, Nakao K, Malhi H. A Comparative Proteomic Analysis of Extracellular Vesicles Associated With Lipotoxicity. Front Cell Dev Biol. 2021; 9:735001 Epub 2021 Nov 04
    View PubMed
  60. Navin PJ, Gidener T, Allen AM, Yin M, Takahashi N, Torbenson MS, Kamath PS, Ehman RL, Venkatesh SK. The Role of Magnetic Resonance Elastography in the Diagnosis of Noncirrhotic Portal Hypertension. Clin Gastroenterol Hepatol. 2020 Dec; 18 (13):3051-3053.e2 Epub 2019 Oct 17
    View PubMed
  61. Peeraphatdit TB, Ahn JC, Choi DH, Allen AM, Simonetto DA, Kamath PS, Shah VH. A Cohort Study Examining the Interaction of Alcohol Consumption and Obesity in Hepatic Steatosis and Mortality. Mayo Clin Proc. 2020 Dec; 95 (12):2612-2620
    View PubMed
  62. Polonis K, Becari C, Chahal CAA, Zhang Y, Allen AM, Kellogg TA, Somers VK, Singh P. Chronic Intermittent Hypoxia Triggers a Senescence-like Phenotype in Human White Preadipocytes. Sci Rep. 2020 Apr 22; 10 (1):6846
    View PubMed
  63. Yang JD, Ahmed F, Mara KC, Addissie BD, Allen AM, Gores GJ, Roberts LR. Diabetes Is Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Cirrhosis From Nonalcoholic Fatty Liver Disease. Hepatology. 2020 Mar; 71 (3):907-916 Epub 2019 Oct 21
    View PubMed
  64. Allen AM, Shah VH, Therneau TM, Venkatesh SK, Mounajjed T, Larson JJ, Mara KC, Schulte PJ, Kellogg TA, Kendrick ML, McKenzie TJ, Greiner SM, Li J, Glaser KJ, Wells ML, Chen J, Ehman RL, Yin M. The Role of Three-Dimensional Magnetic Resonance Elastography in the Diagnosis of Nonalcoholic Steatohepatitis in Obese Patients Undergoing Bariatric Surgery. Hepatology. 2020 Feb; 71 (2):510-521 Epub 2019 Mar 15
    View PubMed
  65. Allen AM, Shah VH, Therneau TM, Venkatesh SK, Mounajjed T, Larson JJ, Mara KC, Kellogg TA, Kendrick ML, McKenzie TJ, Greiner SM, Li J, Glaser KJ, Wells ML, Gunneson TJ, Ehman RL, Yin M. Multiparametric Magnetic Resonance Elastography Improves the Detection of NASH Regression Following Bariatric Surgery. Hepatol Commun. 2020 Feb; 4 (2):185-192 Epub 2019 Nov 05
    View PubMed
  66. Allen AM, Hicks SB, Mara KC, Larson JJ, Therneau TM. The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - A longitudinal cohort study. J Hepatol. 2019 Dec; 71 (6):1229-1236 Epub 2019 Aug 27
    View PubMed
  67. Ahmed OT, Allen AM. Extrahepatic Malignancies in Nonalcoholic Fatty Liver Disease. Curr Hepatol Rep. 2019 Dec; 18 (4):455-472 Epub 2019 Nov 15
    View PubMed
  68. Allen AM, Therneau TM, Mara KC, Larson JJ, Watt KD, Hayes SN, Kamath PS. Women With Nonalcoholic Fatty Liver Disease Lose Protection Against Cardiovascular Disease: A Longitudinal Cohort Study. Am J Gastroenterol. 2019 Nov; 114 (11):1764-1771
    View PubMed
  69. Martin Mateos R, Allen AM. Characterizing specific subgroups in patients with NAFLD: overweight vs obese phenotype. Rev Esp Enferm Dig 2019 Apr; 111 (4):253-255
    View PubMed
  70. Narayanan P, Mara K, Izzy M, Dierkhising R, Heimbach J, Allen AM, Watt KD. Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation. Transplantation. 2019 Jan; 103 (1):e14-e21
    View PubMed
  71. Allen AM, Van Houten HK, Sangaralingham LR, Talwalkar JA, McCoy RG. Healthcare Cost and Utilization in Nonalcoholic Fatty Liver Disease: Real-World Data From a Large U.S. Claims Database. Hepatology. 2018 Dec; 68 (6):2230-2238 Epub 2018 Sept 20
    View PubMed
  72. Allen AM, Heimbach JK, Larson JJ, Mara KC, Kim WR, Kamath PS, Therneau TM. Reduced Access to Liver Transplantation in Women: Role of Height, MELD Exception Scores, and Renal Function Underestimation. Transplantation. 2018 Oct; 102 (10):1710-1716
    View PubMed
  73. Welch BT, Schmitz JJ, Kurup AN, Atwell TD, Callstrom MR, Frey G, Paz-Fumagalli R, Allen A, Watt K, Heimbach J, Schmit GD. Feasibility and outcomes of percutaneous thermal ablation of hepatocellular carcinoma in a transplanted allograft. Abdom Radiol (NY). 2018 Jun; 43 (6):1478-1481
    View PubMed
  74. Allen AM, Therneau TM, Larson JJ, Coward A, Somers VK, Kamath PS. Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study. Hepatology. 2018 May; 67 (5):1726-1736 Epub 2018 Mar 23
    View PubMed
  75. Zhang Y, Somers KR, Becari C, Polonis K, Pfeifer MA, Allen AM, Kellogg TA, Covassin N, Singh P. Comparative Expression of Renin-Angiotensin Pathway Proteins in Visceral Versus Subcutaneous Fat. Front Physiol. 2018; 9:1370 Epub 2018 Oct 10
    View PubMed
  76. Bhanji RA, Narayanan P, Allen AM, Malhi H, Watt KD. Sarcopenia in hiding: The risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis. Hepatology. 2017 Dec; 66 (6):2055-2065 Epub 2017 Oct 30
    View PubMed
  77. Yang JD, Larson JJ, Watt KD, Allen AM, Wiesner RH, Gores GJ, Roberts LR, Heimbach JA, Leise MD. Hepatocellular Carcinoma Is the Most Common Indication for Liver Transplantation and Placement on the Waitlist in the United States. Clin Gastroenterol Hepatol. 2017 May; 15 (5):767-775.e3 Epub 2016 Dec 21
    View PubMed
  78. Allen AM, Kim WR, Moriarty JP, Shah ND, Larson JJ, Kamath PS. Time trends in the health care burden and mortality of acute on chronic liver failure in the United States. Hepatology. 2016 Dec; 64 (6):2165-2172 Epub 2016 Oct 20
    View PubMed
  79. Allen AM, Kim WR. Epidemiology and Healthcare Burden of Acute-on-Chronic Liver Failure. Semin Liver Dis. 2016 May; 36 (2):123-6 Epub 2016 May 12
    View PubMed
  80. Malhi H, Allen AM, Watt KD. Nonalcoholic fatty liver: optimizing pretransplant selection and posttransplant care to maximize survival. Curr Opin Organ Transplant. 2016 Apr; 21 (2):99-106
    View PubMed
  81. Allen AM, Kim WR, Larson JJ, Rosedahl JK, Yawn BP, McKeon K, Hay JE. The Epidemiology of Liver Diseases Unique to Pregnancy in a US Community: A Population-Based Study. Clin Gastroenterol Hepatol. 2016 Feb; 14 (2):287-94.e1-2 Epub 2015 Aug 21
    View PubMed
  82. Singh S, Khera R, Allen AM, Murad MH, Loomba R. Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta-analysis. Hepatology. 2015 Nov; 62 (5):1417-32 Epub 2015 Oct 01
    View PubMed
  83. Allen AM, Kim WR, Larson JJ, Colby C, Therneau TM, Rule AD. Serum Cystatin C as an Indicator of Renal Function and Mortality in Liver Transplant Recipients. Transplantation. 2015 Jul; 99 (7):1431-5
    View PubMed
  84. Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. Clin Gastroenterol Hepatol. 2015 Apr; 13 (4):643-54.e1-9; quiz e39-40 Epub 2014 Apr 24
    View PubMed
  85. Allen AM, Kim WR, Heimbach JK, Rule AD. Reply to: Chronic Kidney Disease (CKD) and NAFLD: Time for hepatologists for awareness and screening J Hepatol.2014;pii:S0168-8278(14)00940-4.
  86. Allen AM, Hay JE. Review article: the management of cirrhosis in women. Aliment Pharmacol Ther. 2014 Nov; 40 (10):1146-54 Epub 2014 Sept 28
    View PubMed
  87. Allen AM, Kim WR, Therneau TM, Larson JJ, Heimbach JK. Rule AD Reply to: Chronic Kidney Disease After Liver Transplantation Journal of Hepatology.2014;S0168-8278 (14)00706-5.
  88. Allen AM, Kim WR, Therneau TM, Larson JJ, Heimbach JK, Rule AD. Chronic kidney disease and associated mortality after liver transplantation--a time-dependent analysis using measured glomerular filtration rate. J Hepatol. 2014 Aug; 61 (2):286-92 Epub 2014 Apr 05
    View PubMed
  89. Allen AM, Kim WR, Xiong H, Liu J, Stock PG, Lake JR, Chinnakotla S, Snyder JJ, Israni AK, Kasiske BL. Survival of recipients of livers from donation after circulatory death who are relisted and undergo retransplant for graft failure. Am J Transplant. 2014 May; 14 (5):1120-8 Epub 2014 Apr 14
    View PubMed
  90. Allen AM, Kim WR, Larson J, Loftus EV Jr. Efficacy and safety of treatment of hepatitis C in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2013 Dec; 11 (12):1655-60.e1 Epub 2013 July 23
    View PubMed